Dover Corporation Form 4 shows director equity grant of 972 units

Rhea-AI Filing Summary

Dover Corporation director reports routine equity grant

A Dover Corporation director filed a Form 4 reporting an award of 972 deferred stock units of Dover common stock on 11/17/2025 at a reference price of $180.05 per share. After this grant, the reporting person beneficially owns 4,959 shares of Dover common stock in total on a direct basis.

The filing explains that these deferred stock units will convert into the same number of Dover common shares when the director’s service on the board ends, providing equity-based compensation that aligns the director’s interests with long-term shareholder value.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DeHaas Deborah L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	972	$180.05	$175K

Holdings After Transaction: Common Stock — 4,959 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeHaas Deborah L

(Last) (First) (Middle)

C/O DOVER CORPORATION

3005 HIGHLAND PARKWAY

(Street)

DOWNERS GROVE IL 60515

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOVER Corp [ DOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		A		972(1)	A	$180.05	4,959	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents grant of deferred stock units which will be payable in an equal number of shares of common stock upon the Reporting Person's termination of services as a director.

	/s/ Deborah L. DeHaas by John C. Nelson as attorney in fact	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DOV report on this Form 4?

The filing reports that a Dover Corporation (DOV) director received 972 deferred stock units of Dover common stock as an equity award on 11/17/2025.

How many Dover (DOV) shares does the director own after this transaction?

After the reported grant, the director beneficially owns 4,959 shares of Dover Corporation common stock on a direct basis.

What are the terms of the deferred stock units granted to the DOV director?

The 972 deferred stock units will be settled in an equal number of Dover common shares when the reporting person’s service as a director terminates.

What was the price associated with the DOV deferred stock unit grant?

The deferred stock unit award is reported at a price of $180.05 per share for Dover Corporation common stock.

What is the director’s relationship to Dover Corporation (DOV)?

The reporting person is identified as a director of Dover Corporation (DOV) and filed the Form 4 as an individual reporting person.

When did the insider transaction for Dover (DOV) occur?

The earliest transaction date reported for the Dover Corporation Form 4 is 11/17/2025.